AquaCure AC50 vs HERO Inhaler 900: caustic-electrolyte Brown's Gas vs pure separated H₂

The AquaCure AC50 (Eagle-Research, distributed via https://aquacureus.com and https://hydrogenoutlet.com) is an alkaline electrolysis generator. A caustic aqueous electrolyte — typically food-grade sodium hydroxide (lye) or potassium hydroxide pellets, per the manufacturer's own operating manual — conducts ions between the electrodes. The output is a single combined gas stream containing roughly 66% H₂ and 33% O₂ by volume, at the stoichiometric ratio of water electrolysis. Yull Brown, the Australian-Bulgarian inventor who patented this class of technology from the 1970s onward, called it "Brown's Gas".

The HERO Inhaler 900 (Hydrogen Machines) is a PEM electrolysis inhaler. A solid proton-exchange-membrane stack splits purified water and separates the hydrogen and oxygen streams at the membrane itself. The user receives a H₂ stream at 600 ml/min through a nasal cannula; the O₂ is vented separately. No liquid electrolyte is added — the machine runs on purified or distilled water alone (TDS < 5).

Neither approach is objectively superior on engineering merit. They are optimising for different things — one for combined Brown's Gas output rooted in Yull Brown's original design lineage, the other for separated pure-H₂ inhalation delivery through a cannula.

While researching this page, we noticed AquaCure's own distributor network publishes at least three different flow-rate figures for the same AC50 SKU, concurrently: up to 50 L/h (about 833 mL/min) of mixed hydrogen–oxygen gas, as published by Eagle-Research; H2HUBB and https://hydrogenoutlet.com publish "640 ml/min, verified"; and hydroproducts.info publishes "75 LPH" (~1,250 ml/min). These are three different numbers on the same physical machine.

We are not adjudicating which figure is correct — that isn't our role, and any of them could be. What we are doing is flagging the inconsistency directly so a buyer can raise it with each seller before purchase and confirm which figure applies to the unit shipping today. This is the same evidentiary treatment we applied to Echo Refresh's certification-page discrepancies in our Echo comparison — noting what's published, not asserting what's true.

Since this page was first published, AquaCure's inventor George Wiseman supplied corrections distinguishing the AC50 from the newer AC60: the AC60 is manufacturer-stated at up to 1,000 ml/min (60 L/hr) of mixed gas, while the AC50 output is up to 50 L/h (about 833 mL/min) of mixed hydrogen–oxygen gas, as published by Eagle-Research. Wiseman also supplied a CE Declaration of Conformity for the AC50 and documents dual-user support and professional suitability for the range.

For contrast: the HERO Inhaler 900 publishes a single figure — 600 ml/min pure H₂ with model-specific gas composition, with 300 ml/min separated O₂, for 900 ml/min total gas at the natural 2:1 ratio. That figure is sourced to one manufacturer spec sheet and is the same across our product page, PDF documentation, and reseller-facing materials.

The AC50's alkaline design requires periodic attention to the electrolyte: weekly distilled-water top-ups to replace what's electrolysed and evaporated, occasional electrolyte-strength adjustment or partial refresh, and per Eagle-Research's own manual, a deep-clean cycle including electrolyte drain and cell inspection every 4-6 months of regular use. Handling caustic electrolyte requires standard PPE (gloves, eye protection) during mixing, refresh, and disposal — this is documented in the manufacturer's manual and is not a criticism of the design, just a factual maintenance profile that alkaline systems require and PEM systems don't.

The HERO Inhaler 900 has no liquid electrolyte to manage. Maintenance is limited to refilling the 3 L purified-water reservoir and running a periodic rinse cycle per the manual. No PPE required for normal operation, no caustic-chemistry handling, no scheduled deep-clean.

Neither is inherently better — they're different tradeoffs. A user who values Brown's Gas output specifically may accept the maintenance cadence for the mechanism; a user who wants set-and-forget operation on purified water will prefer PEM.

The AC50 lists at US$2,499 new on both https://aquacureus.com and https://hydrogenoutlet.com, with an occasional 5% promotion bringing it to US$2,374. A refurbished unit is available at US$1,600 on https://aquacureus.com with what the seller describes as the same lifetime warranty as new. The HERO Inhaler 900 is $2,877 USD / A$4,145.75 AUD, direct from manufacturer, with 24-month warranty and 90-day returns.

On new-unit pricing these two machines are within roughly US$100 of each other — this is not a value-vs-premium comparison, it's a like-for-like price-tier choice between two fundamentally different technologies. The refurbished AC50 at US$1,600 is genuinely cheaper if you're comfortable with a refurbished unit and specifically want the AC50's mechanism.

For a buyer whose priority is separated pure-H₂ inhalation on purified water with a single-source spec sheet, the HERO Inhaler 900 is the direct fit at this price point. For a buyer who specifically wants combined Brown's Gas output and is fine with caustic-electrolyte handling, the AC50 is a legitimate choice and the refurbished tier is meaningfully cheaper. Neither is a marketing framing — they're real product tradeoffs.

AquaCure's marketing invokes Yull Brown's name as the historical originator of Brown's Gas — this is factually correct and a legitimate use of the reference. Yull Brown (Ilya Velbov) filed the foundational patents for the technology from Sydney beginning in the 1970s.

Our reason for mentioning him is more direct: our founder, Peter Griffiths, worked alongside Yull Brown personally from 1985 to 1998 during his tenure at Yull Electronics in Sydney — thirteen years of first-hand engineering collaboration. The connection is documented on our Our Story page with archival photographs and correspondence.

This is a lineage note, not a superiority claim. AquaCure's use of the Brown's Gas name is entirely legitimate. We're noting the direct personal working relationship because it's factually true, sourceable, and part of our own company history — not to imply it makes either device engineering-superior to the other.

Both approaches split water into hydrogen and oxygen using electrical current, and both are long-established industrial electrolysis technologies. The differences are in what conducts the current and what the machine does with the resulting gases.

Alkaline electrolysis (AquaCure AC50): an aqueous electrolyte solution — commonly potassium hydroxide (KOH) or sodium hydroxide (NaOH) — conducts ions between two electrodes separated by a diaphragm or microporous separator. The electrolyte must be present for the cell to work; it is periodically topped up or refreshed per the manufacturer's schedule. The H₂ and O₂ streams may be output combined or separated depending on the specific machine's design. The AC50 outputs them combined.

PEM electrolysis (HERO Inhaler 900): a solid perfluorosulfonic-acid polymer membrane conducts protons directly between the electrodes. No liquid electrolyte is required — the cell runs on distilled or purified water. The membrane physically separates the H₂ and O₂ streams; the H₂ is delivered to the user accessory (cannula or mask) and the O₂ is vented separately. Start-up and shutdown are effectively instant.

Both technologies can produce hydrogen of high purity when correctly designed and maintained; the technology choice mostly determines the maintenance profile, the safety-handling profile, and whether the output stream is combined or separated at the machine.